Alamea Verwaltungs’s Mersana Therapeutics MRSN Stock Holding History

Alamea Verwaltungs’s Portfolio MRSN Stock Details MRSN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-24,165	Closed	-$3.34M	–	91
2025 Q4	$3.34M	Sell	24,165 -405,860	-94%	-$7.71M	2.25%	6
2025 Q3	$3.34M	Buy	430,025 +405,856	+1,679%	+$3.05M	2.28%	6
2025 Q2	$179K	Hold	24,169	–	–	0.13%	89
2025 Q1	$208K	Buy	+24,169	New	+$373K	0.18%	82

Other funds holding MRSN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Alamea Verwaltungs's MRSN Position: Q1 2026 in Review

Alamea Verwaltungs sold out of Mersana Therapeutics (MRSN) in Q1 2026, closing a stake of 24,165 shares — an estimated $3.34M sold.

Alamea Verwaltungs first reported a position in MRSN in Q1 2025 and held it in 4 quarters. The position peaked at $3.34M in Q4 2025. 1 fund tracked by Wall St. Rank holds MRSN as of Q1 2026.

Alamea Verwaltungs reported no remaining Mersana Therapeutics position as of Q1 2026 after selling out during the quarter.
Alamea Verwaltungs sold 24,165 Mersana Therapeutics shares in Q1 2026, an estimated $3.34M.
Alamea Verwaltungs first reported a position in Mersana Therapeutics in Q1 2025 and held it in 4 quarters.
Alamea Verwaltungs's Mersana Therapeutics position peaked at $3.34M in Q4 2025.
1 fund tracked by Wall St. Rank held Mersana Therapeutics as of Q1 2026.

Based on Alamea Verwaltungs's 13F filing for Q1 2026, filed 11 May 2026.